Anticancer Bioscience — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

An oncology biotech using synthetic lethality and genomics to develop precision cancer medicines.

OncologyGenetics & Genomics

A functional genomics and synthetic lethality platform to discover and validate novel precision oncology targets.

Potential to discover groundbreaking new cancer targets and develop highly selective therapies with improved therapeutic windows.

High risk of translational failure from novel genetic targets to effective drugs, and a long, capital-intensive path to the clinic.

Part of a global wave of biotechs using functional genomics for drug discovery, competing on the quality of its target identification.